Confounding factors screened by the CIE method included successful conversion surgery, baseline tumor size, BCLC stage, serum total bilirubin level, number of interventional treatments, alpha-fetoprotein (AFP) level, presence of inferior vena cava tumor thrombus, and partial thrombin activation time (Figure 3). This evidence concerns the gene AFP and neoplasm.